Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | KLK7 | P49862 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15979714 | 0.86 | HPGD (0.53) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL12217640 | 0.86 | HPGD (0.50) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL19458019 | 0.85 | MAPT (0.41) | ALDH1A1L3MBTL1SMN1; SMN2MAPTHTT | |
| SCHEMBL14472222 | 0.85 | HPGD (0.49) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL4531583 | 0.84 | HPGD (0.52) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL128021 | 0.83 | HPGD (0.50) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL9466217 | 0.83 | HPGD (0.55) | HPGDTSHRKLK7POLBALDH1A1 | |
| Hydrochloric Acid SCHEMBL9373093 | 0.81 | HPGD (0.49) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL26179087 | 0.81 | HPGD (0.49) | HPGDTSHRKLK7POLBALDH1A1 | |
| SCHEMBL12349873 | 0.79 | ALDH1A1 (0.49) | HPGDTSHRKLK7POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702620-A | New synthesis method of 6-methyl-2-ethyl-3-hydroxypyridine | 兰州甘涞生物医药有限公司 | 2024-09-27 | — | — | CN | claimed |
| US-11504443-B2 | Odor-modulating agent and odor-modulating method | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2022-11-22 | — | — | US | claimed |
| CN-114672359-A | Lubricating oil | 山本香料株式会社 | 2022-06-28 | — | — | CN | claimed |
| CN-112724076-A | Improved synthesis method of 6-methyl-2-ethyl-3-hydroxypyridine | 浦拉司科技（上海）有限责任公司 | 2021-04-30 | — | — | CN | claimed |
| CN-109689117-B | Odor conversion method | 山本香料株式会社 | 2021-03-30 | — | — | CN | claimed |
| US-20190175777-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2019-06-13 | — | — | US | claimed |
| EP-3467078-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | Yamamoto Perfumery Co. Ltd. (JP) | 2019-04-10 | — | — | EP | claimed |
| EP-2178826-B1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS | MERCK SHARP & DOHME (US) | 2017-05-17 | — | — | EP | claimed |
| US-8519168-B2 | Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds | MERCK SHARP & DOHME CORP. (US) | 2013-08-27 | — | — | US | claimed |
| US-20110160469-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS | MERCK SHARP & DOHME LLC | 2011-06-30 | — | — | US | claimed |
| CN-101932553-A | Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds | SCHERING CORP | 2010-12-29 | — | — | CN | claimed |
| CN-101891677-A | Preparation method of 6-methyl-2-ethyl-3-hydroxy pyridine | UNIV SHAOXING | 2010-11-24 | — | — | CN | claimed |
| EP-2178826-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS | SCHERING CORPORATION (US) | 2010-04-28 | — | — | EP | claimed |
| US-7572757-B1 | Method of treating a well with a gel stabilizer | BJ SERVICES COMPANY (US) | 2009-08-11 | — | — | US | claimed |
| WO-2009005801-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS | SCHERING CORPORATION (US) | 2009-01-08 | — | — | WO | claimed |
| WO-1992019597-A1 | GALLIC ACID DERIVATIVE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | MEDEA RESEARCH S.R.L. (IT) | 1992-11-12 | — | — | WO | claimed |
| US-20260096582-A1 | Edible Products Derived from Insect Protein, and Processes for Making Same | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-3931245-A | FURYLALKYLTHIOL CARBOXYLATES | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160469-A1 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS | CCL2, CCR1, CXCR1 | HPGD 85/4885TSHR 4345/4885KLK7 2160/4885 |
| US-20260096582-A1 | Edible Products Derived from Insect Protein, and Processes for Making Same | CUTA, CHIA, TTPA | HPGD 3716/4885TSHR 1740/4885KLK7 3316/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | HPGD 1580/4885TSHR 3626/4885KLK7 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.